These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

792 related items for PubMed ID: 23223220

  • 1. Peritoneal equilibration test with conventional 'low pH/high glucose degradation product' or with biocompatible 'normal pH/low glucose degradation product' dialysates: does it matter?
    Van Overmeire L, Goffin E, Krzesinski JM, Saint-Remy A, Bovy P, Cornet G, Bovy C.
    Nephrol Dial Transplant; 2013 Jul; 28(7):1946-51. PubMed ID: 23223220
    [Abstract] [Full Text] [Related]

  • 2. Free water transport in children on peritoneal dialysis is higher with more biocompatible dialysis solutions, higher with older age and declines with time.
    Raaijmakers R, Coester A, Smit W, Krediet RT, Schröder CH.
    Nephrol Dial Transplant; 2012 Mar; 27(3):1183-90. PubMed ID: 21771747
    [Abstract] [Full Text] [Related]

  • 3. The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial.
    Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, Jones B, Kulkarni H, Langham R, Ranganathan D, Schollum J, Suranyi MG, Tan SH, Voss D, balANZ Trial Investigators.
    Nephrol Dial Transplant; 2012 Dec; 27(12):4445-53. PubMed ID: 22859794
    [Abstract] [Full Text] [Related]

  • 4. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
    Cara M, Virga G, Mastrosimone S, Girotto A, Rossi V, D'Angelo A, Bonfante L.
    J Nephrol; 2005 Dec; 18(1):67-71. PubMed ID: 15772925
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.
    Clerbaux G, Francart J, Wallemacq P, Robert A, Goffin E.
    Nephrol Dial Transplant; 2006 Apr; 21(4):1032-9. PubMed ID: 16364990
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
    Heimbürger O, Waniewski J, Werynski A, Park MS, Lindholm B.
    Nephrol Dial Transplant; 1994 Apr; 9(1):47-59. PubMed ID: 8177476
    [Abstract] [Full Text] [Related]

  • 11. Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.
    Fang W, Mullan R, Shah H, Mujais S, Bargman JM, Oreopoulos DG.
    Perit Dial Int; 2008 Apr; 28(1):35-43. PubMed ID: 18178946
    [Abstract] [Full Text] [Related]

  • 12. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B, Schmitt CP, Almeida M, Arbeiter K, Ardissino G, Bonzel KE, Edefonti A, Fischbach M, Haluany K, Misselwitz J, Kemper MJ, Rönnholm K, Wygoda S, Schaefer F, European Pediatric Peritoneal Dialysis Study Group.
    BMC Nephrol; 2004 Oct 14; 5():14. PubMed ID: 15485574
    [Abstract] [Full Text] [Related]

  • 13. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
    Park SH, Do JY, Kim YH, Lee HY, Kim BS, Shin SK, Kim HC, Chang YK, Yang JO, Chung HC, Kim CD, Lee WK, Kim JY, Kim YL.
    Nephrol Dial Transplant; 2012 Mar 14; 27(3):1191-9. PubMed ID: 21862454
    [Abstract] [Full Text] [Related]

  • 14. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients.
    Davies SJ.
    Kidney Int; 2004 Dec 14; 66(6):2437-45. PubMed ID: 15569337
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Peritoneal equilibrium test with hypertonic exchange: practical application in a peritoneal dialysis program].
    Ortiz A, Marrón B, Berlanga JR, Reyero A, Gazapo R.
    Nefrologia; 2001 Dec 14; 21(4):362-9. PubMed ID: 11816512
    [Abstract] [Full Text] [Related]

  • 17. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
    Lui SL, Yung S, Yim A, Wong KM, Tong KL, Wong KS, Li CS, Au TC, Lo WK, Ho YW, Ng F, Tang C, Chan TM.
    Am J Kidney Dis; 2012 Dec 14; 60(6):966-75. PubMed ID: 22835900
    [Abstract] [Full Text] [Related]

  • 18. Categorization of sodium sieving by 2.27% and 3.86% peritoneal equilibration tests--a comparative analysis in the clinical setting.
    Gomes AM, Fontán MP, Rodríguez-Carmona A, Sastre A, Cambre HD, Muñiz AL, Falcón TG.
    Nephrol Dial Transplant; 2009 Nov 14; 24(11):3513-20. PubMed ID: 19570887
    [Abstract] [Full Text] [Related]

  • 19. The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test.
    Araújo Teixeira MR, Pecoits-Filho RF, Romão Junior JE, Sabbaga E, Marcondes MM, Abensur H.
    Perit Dial Int; 2002 Nov 14; 22(2):229-33. PubMed ID: 11990408
    [Abstract] [Full Text] [Related]

  • 20. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M, Passadakis P, Kriki P, Gioka T, Panagoutsos S, Mourvati E, Thodis E, Kantartzi K, Vargemezis V.
    Ren Fail; 2008 Nov 14; 30(2):161-7. PubMed ID: 18300115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.